These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11000286)

  • 41. -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis.
    Reynolds WF; Stegeman CA; Tervaert JW
    Clin Immunol; 2002 May; 103(2):154-60. PubMed ID: 12027420
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The antineutrophil cytoplasmic antibody-associated vasculitides.
    Seo P; Stone JH
    Am J Med; 2004 Jul; 117(1):39-50. PubMed ID: 15210387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disease associations and pathogenic role of antineutrophil cytoplasmic autoantibodies in vasculitis.
    Jennette JC; Falk RJ
    Curr Opin Rheumatol; 1992 Feb; 4(1):9-15. PubMed ID: 1543669
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Inflammation phenomena in vasculitis: from immune complexes to less immune forms].
    Blockmans D; Bobbaers H
    Acta Clin Belg; 1998 Apr; 53(2):83-91. PubMed ID: 9639945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antineutrophil cytoplasmic antibodies (ANCA): diagnostic utility and potential role in the pathogenesis of vasculitis.
    Malenica B; Rudolf M; Kozmar A
    Acta Dermatovenerol Croat; 2004; 12(4):294-313. PubMed ID: 15588565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Southwestern Internal Medicine Conference: vasculitis--it's time to reclassify.
    Alpern RJ
    Am J Med Sci; 1995 Apr; 309(4):235-48. PubMed ID: 7900748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ANCA-associated vasculitis: diagnosis, clinical characteristics and treatment.
    Haubitz M
    Vasa; 2007 May; 36(2):81-9. PubMed ID: 17708098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vasculitis in the seriously ill patient: diagnostic approaches and therapeutic options in ANCA-associated vasculitis.
    Schmitt WH; Gross WL
    Kidney Int Suppl; 1998 Feb; 64():S39-44. PubMed ID: 9475487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathways to ANCA production: from differentiation of dendritic cells by proteinase 3 to B lymphocyte maturation in Wegener's granuloma.
    Csernok E; Moosig F; Gross WL
    Clin Rev Allergy Immunol; 2008 Jun; 34(3):300-6. PubMed ID: 18181035
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical applications of antineutrophil cytoplasmic antibody testing.
    Schmitt WH; van der Woude FJ
    Curr Opin Rheumatol; 2004 Jan; 16(1):9-17. PubMed ID: 14673383
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence and disease associations of a proteinase 3-antineutrophil cytoplasmic antibody idiotype (5/7 Id) whose antiidiotype inhibits proteinase 3-antineutrophil cytoplasmic antibody antigen binding activity.
    Strunz HP; Csernok E; Gross WL
    Arthritis Rheum; 1997 Jan; 40(1):135-42. PubMed ID: 9008609
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of Eosinophilic Granulomatosis with Polyangiitis: A Review.
    Raffray L; Guillevin L
    Drugs; 2018 Jun; 78(8):809-821. PubMed ID: 29766394
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The primary vasculitides: a clinicopathologic correlation.
    Narula N; Gupta S; Narula J
    Am J Clin Pathol; 2005 Dec; 124 Suppl():S84-95. PubMed ID: 16468419
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antineutrophil cytoplasm autoantibodies and vasculitis.
    Zhao MH; Short AK; Lockwood CM
    Curr Opin Hematol; 1995 Jan; 2(1):96-102. PubMed ID: 9371977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
    Ozaki S
    Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gynecological involvement in eosinophilic granulomatosis with polyangiitis.
    Sukhdeo A; Bertouch J
    Int J Rheum Dis; 2016 Sep; 19(9):932-5. PubMed ID: 26833810
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical manifestations of antineutrophil cytoplasmic antibodies associated vasculitis].
    Morović-Vergles J; Culo MI; Sutić A
    Lijec Vjesn; 2014; 136(7-8):228-31. PubMed ID: 25327013
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Otolaryngologic manifestations of small vessel vasculitis.
    Metaxaris G; Prokopakis EP; Karatzanis AD; Sakelaris G; Heras P; Velegrakis GA; Helidonis ES
    Auris Nasus Larynx; 2002 Oct; 29(4):353-6. PubMed ID: 12393040
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ANCA-associated renal vasculitis--epidemiology, diagnostics and treatment.
    Ríhová Z; Jancová E; Merta M; Tesar V
    Prague Med Rep; 2004; 105(3):237-60. PubMed ID: 15782551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Postgrad Med J; 2014 May; 90(1063):290-6. PubMed ID: 24737903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.